Z-0656-03
Hybrid Capture 2 High-Risk HPV DNA Test, Catalog # 5101-1296
Qiagen / initiated 2003-02-07 / Terminated
Digene Corp began a recall of Hybrid Capture 2 High-Risk HPV DNA Test, Catalog # 5101-1296 on . The reason FDA records is "In Vitro diagnostic test kit may produce false positive patient results". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-0656-03
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Qiagen
- Product
- Hybrid Capture 2 High-Risk HPV DNA Test, Catalog # 5101-1296
- Product code
- MAQ Kit, Dna Detection, Human Papillomavirus
- Reason for recall
- In Vitro diagnostic test kit may produce false positive patient results
- FDA root cause
- Other
- Action
- The firm notified consignees by phone and fax 2/7/03 and advised of potential for false positive patient results. Firms were instructed to destroy remaining inventory for replacement. Consignees were asked to return response form.
- Quantity in commerce
- 831 kits/ 96 assays per kit
- Distribution
- Domestic product was sold to distributors and end users nationwide and to foreign consignees in Barbados and Spain. Product labeled for export only was distributed to Belgium, Brazil, France, Italy, Portugal, Russia, Slovenia, Spain, Switzerland, Germany and the UK. Firm estimates that 40% of distributed product may remain in user channels.
- Product codes and lots
- Lot 2436/ exp 2003-11
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
